| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3294138 | Gastroenterology | 2012 | 26 Pages |
Abstract
p28GANK activates and maintains liver T-ICs in HCCs by preventing degradation of Oct4. Inhibitors of p28GANK might therefore be developed to inactivate T-ICs and slow tumor progression.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
You-Wen Qian, Yao Chen, Wen Yang, Jing Fu, Jie Cao, Yi-Bin Ren, Jun-Jie Zhu, Bo Su, Tao Luo, Xiao-Fang Zhao, Rong-Yang Dai, Juan-Juan Li, Wen Sun, Meng-Chao Wu, Gen-Sheng Feng, Hong-Yang Wang,